Health care system factors associated with receipt of treatment and treatment intent in stage III non-small cell lung cancer: A population-based study in Ontario
Region of residence emerged as the major health system factor associated with treatment intent for stage III NSCLC. This variation remained, even as advances in radiotherapy and systemic therapy were adopted. Our study suggests possible opportunities to improve care outcomes by addressing unexplained regional variation in care.
Authors
- Fábio Ynoe de Moraes (ORCID: https://orcid.org/0000-0003-3407-9215)
- Stéphane Thibodeau (ORCID: https://orcid.org/0000-0002-7849-1685)
- Paul Nguyen (ORCID: https://orcid.org/0000-0001-7998-293X)
- Andrew Robinson (ORCID: https://orcid.org/0000-0003-1152-4275)
- Jason Pantarotto (ORCID: https://orcid.org/0000-0002-8000-9704)
- Timothy P. Hanna (ORCID: https://orcid.org/0000-0003-3228-6042)
Institutions
- University of Ottawa (CA)
- Queen's University (CA)
Publication Details
- Journal
- Clinical and Translational Radiation Oncology
- Published
- 2024-10-10
- DOI
- https://doi.org/10.1016/j.ctro.2024.100873
- Citations
- 1
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 0.42
Funders
- Ontario Institute for Cancer Research
- Institute for Clinical Evaluative Sciences
- Government of Ontario
- Kementerian Kesihatan Malaysia